Compare PROF & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PROF | NPCT |
|---|---|---|
| Founded | N/A | 2020 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 270.7M | 294.2M |
| IPO Year | 2017 | N/A |
| Metric | PROF | NPCT |
|---|---|---|
| Price | $7.48 | $10.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 145.3K | 131.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.82% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $10,680,000.00 | N/A |
| Revenue This Year | $61.09 | N/A |
| Revenue Next Year | $120.94 | N/A |
| P/E Ratio | $6.41 | ★ N/A |
| Revenue Growth | ★ 48.35 | N/A |
| 52 Week Low | $3.90 | $9.77 |
| 52 Week High | $8.95 | $11.31 |
| Indicator | PROF | NPCT |
|---|---|---|
| Relative Strength Index (RSI) | 55.25 | 47.68 |
| Support Level | $5.31 | $10.15 |
| Resistance Level | $7.95 | $10.75 |
| Average True Range (ATR) | 0.42 | 0.09 |
| MACD | 0.10 | -0.02 |
| Stochastic Oscillator | 75.38 | 20.69 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.